Altre lingue Hainan Poly Pharm. Co., Ltd

Azioni

300630

CNE100002N10

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
7,54 ^CNY	-5,04%		-38,95%	-66,67%

05/07	Hainan Poly Pharm. Co., Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
08/04	Hainan Poly Pharm ottiene l'autorizzazione a commercializzare l'iniezione di Voriconazolo in Svezia	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	05/07
Hainan Poly Pharm's Gets Certification for Invasive Aspergillosis Drug	01/07
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark	25/06
Hainan Poly Pharm Gets US FDA Marketing Nod for Antibacterial Injection	24/06
Hainan Poly Pharm's Unit Gets Nod to Market Raw Drug Ingredient Gadoterate Gluconamide	06/06
China Grants Registration Approval for Antibacterial Drug	14/05
Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities	06/05
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden	08/04
Hainan Poly Pharm Gets Nod to Market Skin Infection Drug in Germany	04/04
Hainan Poly Pharm's Brivaracetam Injection Gets FDA's Nod to Enter US Market; Shares Up 3%	04/03
Hainan Poly Pharm's Epilepsy Drug Gets FDA's Greenlight to Enter US Market	19/02
Hainan Poly Pharm to Apply For Up to 3.8 Billion Yuan Credit Line	11/01
Hainan Poly Pharm Gets Nod to Market Pantoprazole Sodium for Injection in Singapore	12/12
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component A Share Index	11/12
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component Index	11/12
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Hainan Poly Pharm's Gets US FDA Nod to Market Iopamidol Injection	09/10/23
Hainan Poly Pharm Gets Approval to Market Fluconazole Dry Suspension in US	25/09/23
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.	15/09/23
Hainan Poly Pharm. Co., Ltd's Equity Buyback announced on April 25, 2023 has closed with 1,426,700 shares, representing 0.33% for CNY 30.03 million.	14/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hainan Poly Pharm. Co., Ltd

Azioni

300630

CNE100002N10

Altre lingue

Filtri